Your browser doesn't support javascript.
loading
Status and associated factors of cross-regional healthcare-seeking among patients with advanced colorectal cancer in China: a multicenter cross-sectional study.
Zhang, Jian-Gong; Wang, Hong; Gu, Xiao-Fen; Wang, Xiao-Yang; Wang, Wen-Jun; Du, Ling-Bin; Cao, He-Lu; Zhang, Xi; Shi, Ji-Hai; Zhao, Yu-Qian; Ma, Li; Liu, Yun-Yong; Huang, Juan-Xiu; Cao, Ji; Fan, Yan-Ping; Li, Li; Feng, Chang-Yan; Zhu, Qian; Du, Jing-Chang; Wang, Xiao-Hui; Han, Bin-Bin; Qiao, You-Lin.
Afiliação
  • Zhang JG; Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
  • Wang H; Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
  • Gu XF; Department of Student Affairs, Affiliated Tumor Hospital, Xinjiang Medical University, Ürümqi, China.
  • Wang XY; Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
  • Wang WJ; School of Nursing, Jining Medical University, Jining, China.
  • Du LB; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Cao HL; Department of Preventive Health, Xinxiang Central Hospital, Xinxiang, China.
  • Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing, China.
  • Shi JH; The Clinical Epidemiology of Research Center, Department of Dermatological, The First Affiliated Hospital of Baotou Medical College, Baotou, China.
  • Zhao YQ; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Ma L; Public Health School, Dalian Medical University, Dalian, China.
  • Liu YY; Liaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Huang JX; Department of Gastroenterology, Wuzhou Red Cross Hospital, Wuzhou, China.
  • Cao J; Department of Cancer Prevention and Control Office, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Fan YP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li L; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Feng CY; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
  • Zhu Q; School of Public Health and Management, Chongqing Medical University, Chongqing, China.
  • Du JC; School of Public Health, Chengdu Medical College, Chengdu, China.
  • Wang XH; Department of Public Health, Gansu Provincial Cancer Hospital, Lanzhou, China.
  • Han BB; Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
  • Qiao YL; Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Ann Transl Med ; 10(6): 342, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35433943
ABSTRACT

Background:

The imbalanced allocation of medical resources leads to the occurrence of cross-regional healthcare-seeking in China. Due to the low cure rate, advanced colorectal cancer (CRC) patients may seek cross-regional healthcare for high-level medical facilities. Investigating status of cross-regional healthcare-seeking and its associated factors among advanced CRC patients is important for policymakers to understand access to health services and improve the quality of oncology services.

Methods:

From March 2020 to March 2021, a cross­sectional, nation-wide, hospital-based, multi-center survey was conducted. Nineteen hospitals in seven regions were selected by multi-stage stratified sampling. All eligible CRC patients in the selected hospitals were invited to participate in the current study. The outcome variable, cross-regional healthcare-seeking, was defined as seeking health facilities outside the local administration policy of medical insurance. The demographics, clinical information, and medical treatment history of each eligible CRC patient in stage III or IV, were collected through the patients' self-reporting or medical records by trained interviewers. Univariate and multivariate logistic analyses were used to explore the associated factors of cross-regional healthcare-seeking. All statistical analyses were conducted using SAS 9.4.

Results:

A total of 4,589 individuals with advanced CRC were included. The average age of the patients was 60.1±11.6 years, and 59.5% were males. About 37.5% of the patients suffered from metastatic CRC at first diagnosis. Approximately 36.5% of the patients had sought cross-regional health care previously, and among them, 31.9% had encountered problems. The most common problems included complicated procedures (95.3%), unreimbursed expenses of outpatient service (71.0%), and reimbursement delay (59.4%). Logistic regression analysis showed that patients who completed undergraduate or above [odds ratio (OR) =1.40, 95% confidence interval (CI) 1.13-1.73], had an annual household income of more than 100,000 Chinse Yuan (CNY) (OR =1.46, 95% CI 1.21-1.78), and had metastasis at diagnosis (OR =1.33, 95% CI 1.18-1.51) were more likely to seek cross-regional health care.

Conclusions:

About one third of advanced CRC patients seek cross-regional health care, and 31.9% had encountered problems. There is a need to simplify procedures of reimbursement, optimize direct settlement system and referral mechanisms in order to improve the equality of health services.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article